-
1
-
-
0035829842
-
Early goal-directed therapy in the treatment of severe sepsis and septic shock
-
E. Rivers, B. Nguyen, S. Havstad, J. Ressler, and A. Muzzin Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 345 2001 1368 1377
-
(2001)
N Engl J Med
, vol.345
, pp. 1368-1377
-
-
Rivers, E.1
Nguyen, B.2
Havstad, S.3
Ressler, J.4
Muzzin, A.5
-
2
-
-
0343893748
-
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. the Acute Respiratory Distress Syndrome Network
-
The ARDSnet Investigators
-
The ARDSnet Investigators Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network N Engl J Med 342 2000 1301 1308
-
(2000)
N Engl J Med
, vol.342
, pp. 1301-1308
-
-
-
3
-
-
0343360868
-
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group
-
P.C. Hebert, G. Wells, M.A. Blajchman, J. Marshall, and C. Martin A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group N Engl J Med 340 1999 409 417
-
(1999)
N Engl J Med
, vol.340
, pp. 409-417
-
-
Hebert, P.C.1
Wells, G.2
Blajchman, M.A.3
Marshall, J.4
Martin, C.5
-
4
-
-
0035826096
-
Efficacy and safety of recombinant human activated protein C for severe sepsis
-
G.R. Bernard, J.L. Vincent, P.F. Laterre, S.P. LaRosa, and J.F. Dhainaut Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 2001 699 709
-
(2001)
N Engl J Med
, vol.344
, pp. 699-709
-
-
Bernard, G.R.1
Vincent, J.L.2
Laterre, P.F.3
Larosa, S.P.4
Dhainaut, J.F.5
-
5
-
-
1642499233
-
Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia
-
S. Gibot, A. Cravoisy, B. Levy, M.C. Bene, G. Faure, and P.E. Bollaert Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia N Engl J Med 350 2004 451 458
-
(2004)
N Engl J Med
, vol.350
, pp. 451-458
-
-
Gibot, S.1
Cravoisy, A.2
Levy, B.3
Bene, M.C.4
Faure, G.5
Bollaert, P.E.6
-
6
-
-
0033531147
-
A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group
-
R.O. Darouiche, I.I. Raad, S.O. Heard, J.I. Thornby, and O.C. Wenker A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group N Engl J Med 340 1999 1 8
-
(1999)
N Engl J Med
, vol.340
, pp. 1-8
-
-
Darouiche, R.O.1
Raad, I.I.2
Heard, S.O.3
Thornby, J.I.4
Wenker, O.C.5
-
7
-
-
4043130212
-
Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia
-
P. Dodek, S. Keenan, D. Cook, D. Heyland, and M. Jacka Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia Ann Intern Med 141 2004 305 313
-
(2004)
Ann Intern Med
, vol.141
, pp. 305-313
-
-
Dodek, P.1
Keenan, S.2
Cook, D.3
Heyland, D.4
Jacka, M.5
-
8
-
-
0037047431
-
Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention
-
N.P. O'Grady, M. Alexander, E.P. Dellinger, J.L. Gerberding, and S.O. Heard Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention MMWR Recomm Rep 51 2002 1 29
-
(2002)
MMWR Recomm Rep
, vol.51
, pp. 1-29
-
-
O'Grady, N.P.1
Alexander, M.2
Dellinger, E.P.3
Gerberding, J.L.4
Heard, S.O.5
-
9
-
-
22144451498
-
Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence and risk factors
-
D.J. Cook, M. Crowther, M. Meade, C. Rabbat, and L. Griffith Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence and risk factors Crit Care Med 33 2005 1565 1571
-
(2005)
Crit Care Med
, vol.33
, pp. 1565-1571
-
-
Cook, D.J.1
Crowther, M.2
Meade, M.3
Rabbat, C.4
Griffith, L.5
-
10
-
-
0035142879
-
Dosing and monitoring of low-molecular-weight heparins in special populations
-
B.A. Duplaga, C.W. Rivers, and E. Nutescu Dosing and monitoring of low-molecular-weight heparins in special populations Pharmacotherapy 21 2001 218 234
-
(2001)
Pharmacotherapy
, vol.21
, pp. 218-234
-
-
Duplaga, B.A.1
Rivers, C.W.2
Nutescu, E.3
-
11
-
-
0037045781
-
Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors
-
J. Dorffler-Melly, E. de Jonge, A.C. Pont, J. Meijers, and M.B. Vroom Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors Lancet 359 2002 849 850
-
(2002)
Lancet
, vol.359
, pp. 849-850
-
-
Dorffler-Melly, J.1
De Jonge, E.2
Pont, A.C.3
Meijers, J.4
Vroom, M.B.5
-
12
-
-
0037986374
-
Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill?
-
U. Priglinger, G. Delle Karth, A. Geppert, and C. Joukhadar Prophylactic anticoagulation with enoxaparin: is the subcutaneous route appropriate in the critically ill? Crit Care Med 31 2003 1405 1409
-
(2003)
Crit Care Med
, vol.31
, pp. 1405-1409
-
-
Priglinger, U.1
Delle Karth, G.2
Geppert, A.3
Joukhadar, C.4
|